Mitochondrial Abnormalities and Oxidative Imbalance in Neurodegenerative Disease
Overview
Science
Affiliations
An increasing body of evidence now suggests the involvement of mitochondrial abnormalities in the etiology of neurodegenerative diseases, such as Parkinson's disease (PD) and Alzheimer disease. In this Perspective, we describe a recent study that shows that treatment of human patients with the antioxidant coenzyme Q(10'), which functions in concert with certain mitochondrial enzymes, reduced the worsening of symptoms associated with PD. These findings are consistent with the hypothesis that mitochondrial dysfunction plays a role in the pathogenesis of PD and that treatments that target mitochondrial biochemistry might ameliorate the functional decline observed in patients suffering from PD.
ApoE4 dysregulation incites depressive symptoms and mitochondrial impairments in mice.
Li W, Ali T, He K, Zheng C, Li N, Yu Z J Cell Mol Med. 2024; 28(7):e18160.
PMID: 38506067 PMC: 10951871. DOI: 10.1111/jcmm.18160.
Li Q, Li S, Fang J, Yang C, Zhao X, Wang Q Molecules. 2023; 28(14).
PMID: 37513399 PMC: 10385954. DOI: 10.3390/molecules28145527.
The Roles of Coenzyme Q in Disease: Direct and Indirect Involvement in Cellular Functions.
Pallotti F, Bergamini C, Lamperti C, Fato R Int J Mol Sci. 2022; 23(1).
PMID: 35008564 PMC: 8745647. DOI: 10.3390/ijms23010128.
Frontiers in Alzheimer's disease therapeutics.
Stone J, Casadesus G, Gustaw-Rothenberg K, Siedlak S, Wang X, Zhu X Ther Adv Chronic Dis. 2011; 2(1):9-23.
PMID: 21743833 PMC: 3129861. DOI: 10.1177/2040622310382817.
Mitochondrial Drugs for Alzheimer Disease.
Bonda D, Wang X, Gustaw-Rothenberg K, Perry G, Smith M, Zhu X Pharmaceuticals (Basel). 2010; 2(3):287-298.
PMID: 20657666 PMC: 2909133. DOI: 10.3390/ph2030287.